MCID: PRX034
MIFTS: 19

Peroxisome Disorders malady

Category: Rare diseases

Aliases & Classifications for Peroxisome Disorders

About this section

Aliases & Descriptions for Peroxisome Disorders:

Name: Peroxisome Disorders 45
Peroxisomal Disorders 47 65
Disorder of Peroxisomal Function 45
 
Peroxisomal Disease 45
Peroxisome Diseases 45
Peroxisomal Defects 45

Classifications:



Summaries for Peroxisome Disorders

About this section
MalaCards based summary: Peroxisome Disorders, also known as peroxisomal disorders, is related to peroxisome biogenesis disorder 9b and peroxisomal disease. An important gene associated with Peroxisome Disorders is GNPAT (Glyceronephosphate O-Acyltransferase), and among its related pathways are alpha-linolenic (omega3) and linoleic (omega6) acid metabolism and Glyoxylate and dicarboxylate metabolism. Affiliated tissues include kidney, skeletal muscle and lung, and related mouse phenotypes are vision/eye and reproductive system.

Related Diseases for Peroxisome Disorders

About this section

Diseases related to Peroxisome Disorders via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 90)
idRelated DiseaseScoreTop Affiliating Genes
1peroxisome biogenesis disorder 9b30.0HADHB, HSD17B4, PEX5, PEX7
2peroxisomal disease11.8
3severe intellectual disability-epilepsy-cataract syndrome due to fatty acyl-coa reductase 1 deficiency11.3
4peroxisome biogenesis disorder 1a10.4
5peroxisome biogenesis disorder 14b10.3
6alpha-methylacyl-coa racemase deficiency10.3
7d-bifunctional protein deficiency10.3
8peroxisomal fatty acyl-coa reductase 1 disorder10.2
9hyperpipecolatemia10.2
10peroxisome biogenesis disorder 6a10.1
11peroxisome biogenesis disorder 13a10.1
12peroxisome biogenesis disorder 12a10.1
13chondrodysplasia punctata, rhizomelic, type 210.1
14peroxisome biogenesis disorder 11a10.1
15chondrodysplasia punctata, rhizomelic, type 310.1
16peroxisome biogenesis disorder 4a10.1
17chondrodysplasia punctata, rhizomelic, type 110.1
18peroxisome biogenesis disorder 10a10.1
19peroxisome biogenesis disorder 5a10.1
20refsum disease10.1
21acatalasemia10.1
22peroxisome biogenesis disorder 8a,10.1
23peroxisome biogenesis disorder 2a10.1
24peroxisome biogenesis disorder 3a10.1
25peroxisome biogenesis disorder 7a10.1
26adrenoleukodystrophy10.1
27influenza10.0
28adrenomyodystrophy10.0ABCD1, SLC25A17
29discrete subaortic stenosis10.0AGXT, TRIM37
30perrault syndrome 110.0HADHB, HSD17B4
31phosphorylase kinase deficiency10.0PEX1, PEX2, PEX5
32encephalitis9.9
33haemophilus influenzae9.9
34chronic tubotympanic suppurative otitis media9.9ABCD1, PEX5, SLC25A17
35bladder carcinoma in situ9.9PEX1, PEX2, PEX5
36growth hormone deficiency, isolated, type ia9.9PEX1, PEX5, PEX7, TRIM37
37lymphoma9.8
38byssinosis9.8
39sarcoma9.8
40osteoporosis9.8
41legg-calve-perthes disease9.8
42hepatitis9.8
43leukemia9.8
44spinal muscular atrophy9.8
45systemic scleroderma9.8
46chikungunya9.8
47colitis9.8
48sensorineural hearing loss9.8
49cysticercosis9.8
50sleeping sickness9.8

Graphical network of the top 20 diseases related to Peroxisome Disorders:



Diseases related to peroxisome disorders

Symptoms for Peroxisome Disorders

About this section

Drugs & Therapeutics for Peroxisome Disorders

About this section

Drugs for Peroxisome Disorders (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 162)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Telmisartanapproved, investigationalPhase 4, Phase 2260144701-48-465999
Synonyms:
144701-48-4
2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid
4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid
4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid
4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid
4'-((4-mehtyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimmidazolyl)methyl)-2-biphenylcarboxylic acid
4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid
4'-[(1,4'-dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid
4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid
4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl][1,1'-biphenyl]-2-carboxylic acid
4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid
AC-2013
AC1L24EB
AC1Q5U7O
Abbott brand of telmisartan
BAY-68-9291
BAY68-9291
BIBR 277
BIBR 277SE
BIBR-277
BIBR-277-SE
BIBR-277SE
BIDD:GT0365
BRD-K73999723-001-02-2
BSPBio_002738
Bay 68-9291
Bio-0103
Boehringer Ingelheim brand of telmisartan
C07710
C084178
C33H30N4O2
CHEBI:9434
CHEMBL1017
CID65999
CPD000466326
D00627
DB00966
Glaxo Wellcome brand of telmisartan
GlaxoSmithKline brand of telmisartan
 
HMS1922P07
HMS2051P16
HMS2090P17
HMS2093M22
HSDB 7590
I06-0281
KBio3_001958
KBioGR_001842
Kinzal
Kinzalmono
L001035
LS-44263
MLS000759432
MLS001076687
Micardis
Micardis (TN)
Micardis HCT
Micardis, Targit, Temax, BIBR277, Telmisartan
MolPort-003-666-621
NCGC00095150-01
NCGC00095150-02
NCGC00095150-03
Pritor
S1738_Selleck
SAM001246602
SMR000466326
SPBio_002131
SPECTRUM1505261
STK624049
Spectrum2_001976
Spectrum3_001089
Spectrum4_001261
Spectrum5_001053
TL8000991
Telmisartan
Telmisartan (JAN/USAN/INN)
Telmisartan [USAN:INN]
UNII-U5SYW473RQ
YM-086
telmisartan
2
Pioglitazoneapproved, investigationalPhase 4, Phase 3, Phase 2, Phase 1419111025-46-84829
Synonyms:
(+-)-5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione
(+-)-5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione
(+/-)-5-[[4-[2-(5-Ethyl-2-pyridinyl)-ethoxy]phenyl]methyl]-2,4-thiazolidinedione
(+/-)-5-[p-[2-(ethyl-2-pyridyl)ethoxy]benzyl]-2,4-thiazolidinedione
105355-27-9
111025-46-8
198077-89-3
2,4-Thiazolidinedione, 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]- (9CI)
5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione
5-(4-(2-(5-ethyl-2-pyridyl)ethoxy)benzyl)-2,4-thiazolidinedione
5-[4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl]thiazolidine-2,4-dione
5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-thiazolidinedione
5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione
5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]thiazolidine-2,4-dione
5-[[4-[2-[(5-ethyl-2-pyridyl)]ethoxy]phenyl]methyl]thiazolidine- 2,4-dione
5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-1,3-thiazolidine-2,4-dione
AB1004597
AC-1021
AC1L1J1Q
AD 4833
AD-4833
Actos
Actos (TN)
Actost
BRD-A48430263-003-02-4
BSPBio_002723
C07675
C19H20N2O3S
CHEBI:8228
CHEMBL595
CID4829
D08378
DB01132
Duetact
Glustin
HMS2089H14
HS-0047
 
HSDB 7322
I06-0089
KBio2_002103
KBio2_004671
KBio2_007239
KBio3_001943
KBioGR_001619
KBioSS_002103
LS-151327
MolPort-002-508-211
NCGC00163128-01
NCGC00163128-02
Pioglitazona
Pioglitazona [INN-Spanish]
Pioglitazone
Pioglitazone HCl
Pioglitazone Hydrochloride
Pioglitazone [BAN:INN]
Pioglitazone [Ban:Inn]
Pioglitazone [INN:BAN]
Pioglitazonum
Pioglitazonum [INN-Latin]
SPBio_001897
Spectrum2_001679
Spectrum3_001002
Spectrum4_001130
Spectrum5_001480
Spectrum5_002067
Spectrum_001623
U 72107
U 72107A
U-72107
U72,107A
UNII-X4OV71U42S
Zactos
nchembio790-comp10
pioglitazone (INN)
pioglitazone HCl
3
MetforminapprovedPhase 4, Phase 3, Phase 21645657-24-9, 1115-70-414219, 4091
Synonyms:
1,1-Dimethyl biguanide
1,1-Dimethylbiguanide
3-(diaminomethylidene)-1,1-dimethylguanidine
657-24-9
AC1L1HE4
AKOS000121065
Apo-Metformin
BIDD:GT0697
BPBio1_000009
BRD-K79602928-003-04-1
BSPBio_000007
BSPBio_002314
C07151
C4H11N5
CAS-1115-70-4
CCRIS 9321
CHEBI:6801
CHEMBL1431
CID4091
D04966
DB00331
DMBG
DMGG
Diabefagos
Diabetosan
Diabex
Diaformin
Dianben
Dimethylbiguanid
Dimethylbiguanide
Dimethylbiguanidine
Dimethyldiguanide
Dimethylguanylguanidine
EINECS 211-517-8
Fluamine
Flumamine
Fortamet
Gen-Metformin
Glifage
Gliguanid
Glucophage
Glucophage XR
Glumetza
Glycon
HMS2089D19
HSCI1_000295
Haurymelin
Haurymellin
Islotin
KBio2_002310
KBio2_004878
KBio2_007446
KBio3_002790
KBioGR_002310
 
KBioSS_002312
LA-6023
LS-43899
Meguan
Melbin
Metformin
Metformin (USAN/INN)
Metformin HCL
Metformin Hydrochloride
Metformin [USAN:INN:BAN]
Metformina
Metformina [DCIT]
Metformina [Spanish]
Metformine
Metformine [INN-French]
Metformine pamoate
Metforminum
Metforminum [INN-Latin]
Metiguanide
MolPort-002-929-560
MolPort-004-288-389
MolPort-005-767-418
Mylan-Metformin
N,N-Dimethylbiguanide
N,N-Dimethyldiguanide
N,N-Dimethylimidodicarbonimidic diamide
N,N-dimethylimidodicarbonimidic diamide
N1,N1-Dimethylbiguanide
NCGC00016564-01
NCGC00016564-02
NCGC00016564-03
NNDG
Novo-Metformin
Nu-Metformin
Obimet
PMS-Metformin
Prestwick0_000004
Prestwick1_000004
Prestwick2_000004
Prestwick3_000004
Ran-Metformin
Ratio-Metformin
Riomet
S2483_Selleck
SPBio_001928
STK011633
Sandoz Metformin
Siofor
T5895664
Teva-Metformin
UNII-9100L32L2N
ZINC12859773
cMAP_000016
metformin
metformin hydrochloride
4
Valsartanapproved, investigationalPhase 4268137862-53-460846
Synonyms:
(2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid
(S)-N-Valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine
(S)-N-valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine
(s)-2-(n-((2'-(1h-tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)-3-methylbutanoic acid
137862-53-4
AC-4543
AC1L1U1M
AC1Q5QIK
Ambap137862-53-4
Aventis brand of valsartan
BIDD:GT0345
BRD-K45158365-001-02-3
BSPBio_003501
Bio-0796
C081489
C24H29N5O3
CEPA brand of valsartan
CGP 48933
CGP-48933
CHEBI:9927
CHEMBL1069
CID60846
CPD000466318
D00400
DB00177
Diovan
Diovan (TN)
Diovan, Valsartan
Esteve brand of valsartan
HMS1922L21
HMS2051L12
HMS2093K22
HSDB 7519
KBio2_002287
KBio2_004855
KBio2_007423
KBio3_003006
KBioGR_001078
KBioSS_002289
Kalpress
 
L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- (9CI)
LS-161334
Lacer brand of valsartan
MLS000759423
MLS001424088
Miten
MolPort-002-507-854
MolPort-003-666-608
N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine
N-(P-(O-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine
N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine
N-Pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine
N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-L-valine
N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine
N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine
Nisis
Nisis||
Novartis brand of valsartan
Provas
S1894_Selleck
SAM001246581
SMR000466318
SPBio_001260
SPECTRUM1505209
Sanol brand of valsartan
Schwarz brand of valsartan
Spectrum2_001120
Spectrum3_001831
Spectrum4_000749
Spectrum5_001582
Spectrum_001796
TL8000869
Tareg
UNII-80M03YXJ7I
Vals
Valsarran
Valsartan
Valsartan (JAN/USAN/INN)
Valsartan [USAN:INN]
valsartan
walsartan
|Tareg
5
GlimepirideapprovedPhase 422193479-97-13476
Synonyms:
1-((p-(2-(3-Ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido)ethyl)phenyl)sulfonyl)-3-(trans-4-methylcyclohexyl)urea
1-{[4-(2-{[(3-ethyl-4-methyl-2-oxo-2,5-dihydro-1H-pyrrol-1-yl)carbonyl]amino}ethyl)phenyl]sulfonyl}-3-(trans-4-methylcyclohexyl)urea
3-ethyl-4-methyl-N-[2-(4-{[(trans-4-methylcyclohexyl)carbamoyl]sulfamoyl}phenyl)ethyl]-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide
3-ethyl-4-methyl-n-(4-(n-((1r,4r)-4-methylcyclohexylcarbamoyl)sulfamoyl)phenethyl)-2-oxo-2,5-dihydro
4-ethyl-3-methyl-N-[2-[4-[(4-methylcyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide
64598P
93479-97-1
AB00513874
AC-476
AC1L1G0T
Amarel
Amaryl
Amaryl (TN)
Amaryl, Glista OD, Glimepiride
Avaglim
BPBio1_000751
BRD-K34776109-001-03-4
BRD-K42693031-001-01-8
BRN 5365754
BSPBio_000681
Bio-0049
C07669
C24H34N4O5S
CAS-93479-97-1
CCRIS 7083
CHEBI:5383
CHEMBL1481
CID3476
CPD000466368
D00593
DB00222
Endial
G2295_SIGMA
Glimepirid
Glimepirida
Glimepirida [Spanish]
Glimepiride
Glimepiride (JAN/USP/INN)
Glimepiride [USAN:BAN:INN]
Glimepiridum
 
Glimepiridum [Latin]
Glimepride
Glimer
Glimépiride
Glymepirid
HMS1570C03
HMS2052L03
HMS2090K18
HOE 490
Hoe-490
I06-0029
I06-2285
LS-136752
MLS000759495
MLS001076674
MLS001401419
MolPort-003-847-587
MolPort-003-987-461
MolPort-005-941-721
NCGC00016960-01
NCGC00161404-01
NCGC00161404-02
NCGC00181757-01
Novo-glimepiride
Oprea1_382896
PMS-glimepiride
Prestwick0_000651
Prestwick1_000651
Prestwick2_000651
Prestwick3_000651
Ratio-glimepiride
Roname
S1344_Selleck
SAM001246710
SMR000466368
SPBio_002602
Sandoz glimepiride
Solosa
TL8005924
UNII-6KY687524K
ZINC00537791
glimepiride
6Hormone AntagonistsPhase 4, Phase 3, Phase 210002
7HIV Protease InhibitorsPhase 4, Phase 34558
8HormonesPhase 4, Phase 3, Phase 211748
9IncretinsPhase 4, Phase 31326
10Hypoglycemic AgentsPhase 4, Phase 3, Phase 2, Phase 14503
11Sitagliptin PhosphatePhase 4, Phase 3399
12Protease InhibitorsPhase 4, Phase 34558
13Dipeptidyl-Peptidase IV InhibitorsPhase 4, Phase 3779
14Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 3, Phase 29988
152,4-thiazolidinedionePhase 4, Phase 296
16
Angiotensin IIPhase 4, Phase 2103368521-88-0, 11128-99-7172198, 65143
Synonyms:
1-8-Angiotensin I
1-L-Aspasaginyl-5-L-valyl angiotensin octapeptide
Ang II
Angiotensin 2
Angiotensin II (human)
 
Angiotensin II (mouse)
Angiotonin
Asp-arg-val-TYR-ile-his-pro-phe
Human angiotensin II
Hypertensin
Ile(5)-angiotensin II
17Insulin, Globin ZincPhase 4, Phase 3, Phase 24278
18insulinPhase 4, Phase 3, Phase 24278
19Angiotensin II Type 1 Receptor BlockersPhase 4, Phase 2949
20Contraceptives, OralPhase 4, Phase 2, Phase 13734
21Angiotensin Receptor AntagonistsPhase 4, Phase 21039
22AngiotensinogenPhase 4, Phase 21032
23Antihypertensive AgentsPhase 4, Phase 23618
24
Cyclophosphamideapproved, investigationalPhase 2, Phase 3264350-18-0, 6055-19-22907
Synonyms:
(+-)-Cyclophosphamide
(-)-Cyclophosphamide
(RS)-Cyclophosphamide
1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine
1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin
2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide
4-Hydroxy-cyclophosphan-mamophosphatide
50-18-0
60007-95-6
6055-19-2 (monohydrate)
75526-90-8
AC1L1EQQ
AI3-26198
ASTA
ASTA B518
Asta B 518
B 518
B-518
BRN 0011744
BSPBio_002099
Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester
C 0768
C07888
C7H15Cl2N2O2P
CB 4564
CB-4564
CCRIS 188
CHEBI:4027
CHEMBL32520
CHEMBL88
CID2907
CP
CPA
CTX
CY
Ciclofosfamida
Ciclofosfamida [INN-Spanish]
Ciclofosfamide
Ciclophosphamide
Ciclophosphamide [INN]
Clafen
Claphene
Cycloblastin
Cyclophosphamid
Cyclophosphamide
Cyclophosphamide (INN)
Cyclophosphamide (TN)
Cyclophosphamide (anhydrous form)
Cyclophosphamide (anhydrous)
Cyclophosphamide Monohydrate
Cyclophosphamide Sterile
Cyclophosphamide anhydrous
Cyclophosphamide, (+-)-Isomer
Cyclophosphamides
Cyclophosphamidum
Cyclophosphamidum [INN-Latin]
Cyclophosphan
Cyclophosphane
Cyclophosphanum
Cyclophosphoramide
Cyclostin
Cyklofosfamid
Cyklofosfamid [Czech]
Cytophosphan
Cytophosphane
Cytoxan
Cytoxan (TN)
Cytoxan Lyoph
D,L-Cyclophosphamide
D07760
DB00531
 
DivK1c_000246
EINECS 200-015-4
EU-0100238
Endoxan
Endoxan R
Endoxan-Asta
Endoxana
Endoxanal
Endoxane
Enduxan
Genoxal
HMS2090A12
HSDB 3047
Hexadrin
IDI1_000246
KBio1_000246
KBio2_001338
KBio2_003906
KBio2_006474
KBio3_001319
KBioGR_000888
KBioSS_001338
LS-1302
LS-99787
Ledoxina
Lopac-C-0768
Lopac0_000238
Lyophilized Cytoxan
Mitoxan
MolPort-001-783-420
N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide
N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
NCGC00015209-01
NCGC00015209-03
NCGC00015209-06
NCGC00091741-02
NCGC00091741-03
NCI-C04900
NCI60_002097
NINDS_000246
NSC 26271
NSC-26271
NSC26271
NSC273033
NSC273034
Neosar
Occupation, cyclophosphamide exposure
Procytox
RCRA waste no. U058
Rcra Waste Number U058
Rcra waste number U058
Revimmune
S1217_Selleck
SK 20501
SPBio_001071
STK177249
STOCK2S-91217
Semdoxan
Sendoxan
Senduxan
Spectrum2_001146
Spectrum3_000370
Spectrum4_000304
Spectrum5_000795
Spectrum_000858
UNII-6UXW23996M
WLN: T6MPOTJ BO BN2G2G
Zyklophosphamid
Zyklophosphamid [German]
bis(2-Chloroethyl)phosphami de cyclic propanolamide
bis(2-Chloroethyl)phosphamide cyclic propanolamide ester
cyclophosphamide
25
MethylprednisoloneapprovedPhase 2, Phase 3108283-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
A-methapred
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Depo-medrol
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Solu-medrol
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
26
PrednisoloneapprovedPhase 2, Phase 3108250-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
Flo-pred
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
MLS001304083
 
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
Millipred
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Omnipred
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone
27
GlipizideapprovedPhase 33829094-61-93478
Synonyms:
1-Cyclohexyl-3-((p-(2-(5-methylpyrazinecarboxamido)ethyl)phenyl)sulfonyl)urea
1-Cyclohexyl-3-({p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl}sulfonyl)urea
1-Cyclohexyl-3-{4-[2-(5-methylpyrazine-2-carboxamido)ethyl]phenylsulfonyl}urea
172964-66-8
29094-61-9
29094-66-4
30553_FLUKA
38777-27-4
AC-15789
AC1L1G0Z
AC1Q2OG0
Aldiab
Alphapharm Brand of Glipizide
BIDD:GT0476
BPBio1_000224
BRD-K12219985-001-04-8
BRN 0903495
BSPBio_000202
BSPBio_001349
Bio-0161
Bio1_000074
Bio1_000563
Bio1_001052
Bio2_000069
Bio2_000549
C21H27N5O4S
CAS-29094-61-9
CBiol_001788
CHEBI:239286
CHEMBL1073
CID3478
CP 28,720
CP 28720
CP-28,720
CP-28720
CPD000058455
D00335
D005913
DB01067
Digrin
Dipazide
EINECS 249-427-6
EU-0100621
G-117
G117_SIGMA
Glibenese
Glibenese Brand of Glipizide
Glibetin
Glican
Glide
Glidiab
Glidiazinamide
Glipid
Glipizida
Glipizida [INN-Spanish]
Glipizide
Glipizide (USP/INN)
Glipizide ER
Glipizide Extended-Release Tablets
Glipizide Kenfarma Brand
Glipizide XL
Glipizide Xl
Glipizide [USAN:BAN:INN]
Glipizideer
Glipizideer ER
Glipizidum
Glipizidum [INN-Latin]
Gluco-Rite
Gluco-rite
Glucolip
Glucotrol
Glucotrol (TN)
Glucotrol XL
Glucotrol XL, Glucotrol, Glipizide
Glucotrol Xl
Glucozide
Glupitel
 
Glupizide
Glyde
Glydiazinamide
Glypidizine
HMS1361D11
HMS1568K04
HMS1791D11
HMS1989D11
HMS2089C21
HMS2093J09
I06-0186
I06-1985
IDI1_033819
K 4024
K-4024
K4024
KBio2_000069
KBio2_002637
KBio2_005205
KBio3_000137
KBio3_000138
KBioGR_000069
KBioSS_000069
KS-1068
Kenfarma Brand of Glipizide
LS-159679
Lacer Brand of Glipizide
Lilly Brand of Glipizide
Lopac-G-117
Lopac0_000621
MLS000069386
MLS001148176
Melizide
Metaglip
Mindiab
Minidab
Minidiab
Minodiab
MolPort-002-885-830
MolPort-003-666-685
N-(2-{4-[(cyclohexylcarbamoyl)sulfamoyl]phenyl}ethyl)-5-methylpyrazine-2-carboxamide
N-(4-(beta-(5-Methylpyrazine-2-carboxamido)ethyl)benzenesulphonyl)-N'-cyclohexylurea
N-[2-(4-{[(cyclohexylcarbamoyl)amino]sulfonyl}phenyl)ethyl]-5-methylpyrazine-2-carboxamide
N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methylpyrazine-2-carboxamide
N-{4-[beta-(5-methylpyrazine-2-carboxamido)ethyl]benzenesulphonyl}-n'-cyclohexylurea
NCGC00015462-01
NCGC00015462-02
NCGC00015462-05
NCGC00015462-11
NCGC00016802-01
NCGC00023748-03
NCGC00023748-04
NCGC00023748-05
NCGC00023748-06
NCGC00023748-07
Napizide
Ozidia
Pfizer Brand 1 of Glipizide
Pfizer Brand 2 of Glipizide
Prestwick0_000131
Prestwick1_000131
Prestwick2_000131
Prestwick3_000131
Prestwick_242
S1715_Selelck
S1715_Selleck
SAM002564210
SMR000058455
SPBio_002141
STK631952
Samarium(III) ionophore I
Semiglynase
Sucrazide
TK 1320
TL8006447
UNII-X7WDT95N5C
ZINC00537795
glipizide
nchembio.128-comp32
28
Busulfanapproved, investigationalPhase 2, Phase 350655-98-12478
Synonyms:
1, 4-Dimethanesulfonoxybutane
1, 4-Dimethylsulfonoxybutane
1, {4-Bis[methanesulfonoxy]butane}
1,4-BUTANEDIOL DIMETHANESULFONATE
1,4-Bis(methanesulfonoxy)butane
1,4-Bis(methanesulfonyloxy)butane
1,4-Bis[methanesulfonoxy]butane
1,4-Butanedi yl dimethanesulfonate
1,4-Butanediol dimethanesulfonate
1,4-Butanediol dimethanesulphonate
1,4-Butanediol dimethylsulfonate
1,4-Butanediol, dimethanesulfonate
1,4-Butanediol, dimethanesulphonate
1,4-Butanediyl dimethanesulfonate
1,4-Di(methylsulfonoxy)butane
1,4-Dimesyloxybutane
1,4-Dimethane sulfonyl oxybutane
1,4-Dimethanesulfonoxybutane
1,4-Dimethanesulfonoxylbutane
1,4-Dimethanesulfonyloxybutane
1,4-Dimethanesulphonyloxybutane
1,4-Dimethylsulfonoxybutane
1,4-Dimethylsulfonyloxybutane
2041 C. B
2041 C. B.
2041 C.B
2041 C.B.
4-((Methylsulfonyl)oxy)butyl methanesulfonate
4-methylsulfonyloxybutyl methanesulfonate
55-98-1
AC-198
AC1L1DRQ
AC1Q4GRQ
AI3-25012
AKOS003614975
AN 33501
Ambap55-98-1
B1022
B2635_FLUKA
B2635_SIGMA
BRN 1791786
BSPBio_001920
BUSULFAN (1,4-BUTANEDIOL, DIMETHANESULFONATE)
Bisulfex
Busilvex
Busulfan
Busulfan (JP15/USP/INN)
Busulfan GlaxoSmithKline Brand
Busulfan Orphan Brand
Busulfan Wellcome
Busulfan Wellcome Brand
Busulfan [INN:JAN]
Busulfano
Busulfano [INN-Spanish]
Busulfanum
Busulfanum [INN-Latin]
Busulfex
Busulphan
Busulphane
Butanedioldimethanesulfonate
Buzulfan
C.B. 2041
C6H14O6S2
CB 2041
CCRIS 418
CHEBI:28901
CHEMBL820
CID2478
CPD000058613
Citosulfan
D002066
D00248
DB01008
DivK1c_000847
EINECS 200-250-2
FT-0083567
G.T. 41
GT 2041
GT 41
Glaxo Wellcome Brand of Busulfan
GlaxoSmithKline Brand of Busulfan
Glyzophrol
HMS1920I07
HMS2091O09
HMS502K09
 
HSDB 7605
I09-1371
IDI1_000847
InChI=1/C6H14O6S2/c1-13(7,8)11-5-3-4-6-12-14(2,9)10/h3-6H2,1-2H3
KBio1_000847
KBio2_000512
KBio2_003080
KBio2_005648
KBio3_001420
KBioGR_000698
KBioSS_000512
LS-1358
Leucosulfan
MLS001076666
MYLERAN (TN)
Mablin
Methanesulfonic
Methanesulfonic acid, tetram ethylene ester
Methanesulfonic acid, tetramethylene ester
Mielevcin
Mielosan
Mielucin
Milecitan
Mileran
Misulban
Mitosan
Mitostan
MolPort-001-783-406
Myeleukon
Myeloleukon
Myelosan
Myelosanum
Mylecytan
Myleran
Myleran Tablets
Myleran tablets
Myleran, Busulfex, Busulfan
Mylerlan
NCGC00090905-01
NCGC00090905-02
NCGC00090905-03
NCGC00090905-04
NCGC00090905-05
NCGC00090905-06
NCGC00090905-07
NCI-C01592
NCI60_041640
NCIMech_000192
NINDS_000847
NSC 750
NSC-750
NSC-750sulphabutin
NSC750
Orphan Brand of Busulfan
Prestwick_989
S1692_Selleck
SAM002554887
SMR000058613
SPBio_000253
SPECTRUM1500152
ST50825921
Spectrum2_000067
Spectrum3_000320
Spectrum4_000259
Spectrum5_000928
Spectrum_000092
Sulfabutin
Sulfabutin (VAN)
Sulphabutin
Tetramethylene Dimethane Sulfonate
Tetramethylene bis(methanesulfonate)
Tetramethylene bis[methanesulfonate]
Tetramethylene dimethane sulfonate
Tetramethylene {bis[methanesulfonate]}
Tetramethylenester Kyseliny Methansulfonove
Tetramethylenester kyseliny methansulfonove
Tetramethylenester kyseliny methansulfonove [Czech]
UNII-G1LN9045DK
WLN: WS1&O4OSW1
Wellcome Brand of Busulfan
Wellcome, Busulfan
X 149
acid, tetramethylene ester
alkylating agent: crosslinks guanine residues
busulfan
butane-1,4-diyl dimethanesulfonate
n-Butane-1,3-di(methylsulfonate)
29
Rosiglitazoneapproved, investigationalPhase 3, Phase 2, Phase 1220122320-73-477999
Synonyms:
(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion
(±)-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione
122320-73-4
2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]- (9CI)
5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione
5-((4-(2-Methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate
5-(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}benzyl)-1,3-thiazolidine-2,4-dione
5-[4-[2-(N-Methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
5-[[4-[2-(methyl-(2-pyridyl)amino)ethoxy]phenyl]methyl] thiazolidine-2,4-dione
5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione
AC-3459
AC1L2U9N
Avandia
BRD-A97437073-001-02-3
BRD-A97437073-001-03-1
BRL49653
BSPBio_002693
Brl 49653
Brl-49653
C18H19N3O3S
CID77999
D08491
DB00412
Gaudil
Gaudil (TN)
HMS1922J11
HMS2094O13
HSDB 7555
I06-0141
IDMB (1uM BRL49653, 1uM Dexamethasone, 0.5uM IBMX, 10ug/mL Insulin)
KBio2_002183
KBio2_004751
KBio2_007319
KBio3_001913
KBioGR_001609
 
KBioSS_002183
LS-151340
MolPort-002-508-212
NCGC00095124-01
NCGC00095124-02
NCGC00095124-03
RGZ
RSG
Rosi
Rosigilitazone
Rosigliazone maleate
Rosiglitazon
Rosiglitazona
Rosiglitazone
Rosiglitazone (INN)
Rosiglitazone Maleate
Rosiglitazone [INN:BAN]
Rosiglitazone maleate
Rosiglitazonum
Rosiglizole
S00306
SPBio_001142
SPECTRUM1504263
STOCK6S-23924
Spectrum2_001241
Spectrum3_000997
Spectrum4_001125
Spectrum5_001464
Spectrum_001703
TDZ 01
UNII-05V02F2KDG
[3H]rosiglitazone
rosiglitazona
rosiglitazone
rosiglitazone (Avandia)
rosiglitazonum
30
Dimethyl sulfoxideapprovedPhase 2, Phase 32967-68-5679
Synonyms:
(CH3)2SO
(methylsulfinyl)methane
DMSO
Dimethyl sulfoxide
Dimethyl sulfoxixde
Dimethyl sulfur oxide
Dimethyl sulphoxide
 
Dimethyl sulpoxide
Dimethyli sulfoxidum
Dimethylsulfoxid
Dimethylsulfoxyde
Dimetil sulfoxido
Methylsulfinylmethane
Rimso-50
S(O)Me2
Sulfinylbis(methane)
31
GlycerolexperimentalPhase 2, Phase 319156-81-5753
Synonyms:
1,2,3-Trihydroxypropane
Bulbold
Cristal
E 422
Emery 916
Glyceol Opthalgan
Glycerin
Glycerine
Glyceritol
Glycerol
 
Glycyl alcohol
Glyrol
Glysanin
IFP
Incorporation factor
Mackstat H 66
Osmoglyn
Pricerine 9091
Propanetriol
RG-S
Trihydroxypropane
Tryhydroxypropane
32Prednisolone phosphatePhase 2, Phase 31082
33Prednisolone hemisuccinatePhase 2, Phase 31082
34Bile Acids and SaltsPhase 386
35Hypolipidemic AgentsPhase 3, Phase 22228
36Antineoplastic Agents, AlkylatingPhase 2, Phase 33406
37Prednisolone acetatePhase 2, Phase 31082
38AntimetabolitesPhase 3, Phase 29454
39Cholic AcidsPhase 311
40Antilymphocyte SerumPhase 2, Phase 3388
41Immunologic FactorsPhase 2, Phase 318483
42Alkylating AgentsPhase 2, Phase 33582
43Immunosuppressive AgentsPhase 2, Phase 3, Phase 110422
44Antirheumatic AgentsPhase 2, Phase 3, Phase 18496
45Methylprednisolone HemisuccinatePhase 2, Phase 31082
46Methylprednisolone acetatePhase 2, Phase 31082
47Liver ExtractsPhase 3, Phase 23572
48Gastrointestinal AgentsPhase 3, Phase 26401
49lenograstimPhase 2, Phase 31134
50
BetainePhase 332107-43-7247
Synonyms:
(Carboxymethyl)trimethylammonium hydroxide inner salt
(Trimethylammonio)acetate
1-Carboxy-N,N,N-trimethyl-Methanaminium
1-Carboxy-N,N,N-trimethyl-Methanaminium hydroxide
1-Carboxy-N,N,N-trimethylmethanaminium inner salt
Abromine
Aminocoat
Betafin
Betafin BCR
Betafin BP
Betaine
Cystadane
Ektasolve EE
FinnStim
Glycine betaine
 
Glycocoll betaine
Glycylbetaine
Greenstim
Loramine AMB 13
Loramine AMB-13
Lycine
N,N,N-Trimethylglycine
Oxyneurine
Rubrine C
Trimethylaminoacetate
Trimethylaminoacetic acid
Trimethylbetaine Glycine
Trimethylglycine
Trimethylglycocoll
a-Earleine
alpha-Earleine

Interventional clinical trials:

(show top 50)    (show all 100)
idNameStatusNCT IDPhase
1Observational Study to Assess Glycosylated Hemoglobin Changes After 6 Months of Treatment With Pioglitazone.CompletedNCT00449553Phase 4
2Efficacy Study of Pioglitazone and Metformin and Association Between Pioglitazone Response and Peroxisome Proliferator-activated Receptor Gamma Gene Variants in Bangladeshi Type 2 Diabetes Mellitus SubjectsCompletedNCT01589445Phase 4
3Peroxisome Proliferator-Activated Receptor-Gamma Activation in Peritoneal Dialysis PatientsCompletedNCT00745225Phase 4
4A 24 Week, Multicenter, Prospective, Open-labeled, Single-arm, Exploratory Phase 4 Clinical Trial to Evaluate the Safety and Efficacy of Lobeglitazone in Decreasing Intrahepatic Fat Contents in Type 2 Diabetes With NAFLDCompletedNCT02285205Phase 4
5Comparison of Effects of Telmisartan and Valsartan on Neointima Volume in DiabetesCompletedNCT00599885Phase 4
6The Effects of Peroxisome Proliferators Activated Receptor-Gamma (PPAR-γ) Agonists on Certain Biochemical and Inflammatory Markers in Metabolic SyndromeCompletedNCT00926341Phase 4
7Triple Combination Therapy in Type 2 Diabetic Patients Who Had Inadequate Glycemic Control With Combination TherapyRecruitingNCT02338921Phase 4
8Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic AcidCompletedNCT00007020Phase 3
9Stem Cell Transplant for Inborn Errors of MetabolismCompletedNCT00176904Phase 2, Phase 3
10PPAR-gamma Agonists, Rheumatoid Arthritis and Cardiovascular DiseaseCompletedNCT00554853Phase 3
11Role of Rosiglitazone on Pre-Diabetes Mellitus and Coronary Artery DiseaseCompletedNCT01574820Phase 3
12Effect of Pioglitazone Administered to Patients With Friedreich's Ataxia: Proof of ConceptCompletedNCT00811681Phase 3
13Effects of Pioglitazone on High-density Lipoprotein (HDL) Function in Persons With DiabetesCompletedNCT01156597Phase 3
14Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052)CompletedNCT00350779Phase 3
15Betaine and Peroxisome Biogenesis DisordersRecruitingNCT01838941Phase 3
16A Phase 2/3 Study of the Efficacy and Safety of Hematopoietic Stem Cells Transduced With Lenti-D Lentiviral Vector for the Treatment of Childhood Cerebral Adrenoleukodystrophy (CCALD)Active, not recruitingNCT01896102Phase 2, Phase 3
17Rosiglitazone Plaque StudyActive, not recruitingNCT00123227Phase 3
18Effect of Glycerol Trierucate on Clinical Course of AdrenoleukodystrophySuspendedNCT00004418Phase 2, Phase 3
19A Phase III Trial of Lorenzo's Oil in AdrenomyeloneuropathyTerminatedNCT00545597Phase 3
20ALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transfusion (UCBT) in Patients With Inherited Metabolic DiseasesTerminatedNCT00654433Phase 3
21Endometriosis: ImmunomodulationWithdrawnNCT01184144Phase 2, Phase 3
22Effect of Rosiglitazone on Peritoneal Cytokines in Women With EndometriosisWithdrawnNCT00121953Phase 2, Phase 3
23HSCT for High Risk Inherited Inborn ErrorsCompletedNCT00383448Phase 2
24A Clinical Trial for AMN: Validation of Biomarkers of Oxidative Stress, Efficacy and Safety of a Mixture of AntioxidantsCompletedNCT01495260Phase 2
25Canakinumab in Patients With Active Hyper-IgD SyndromeCompletedNCT01303380Phase 2
26Rosiglitazone in the Treatment of HIV-Associated HyperlipidemiaCompletedNCT00006493Phase 2
27Treatment of Nonalcoholic Steatohepatitis With PioglitazoneCompletedNCT00013598Phase 2
28Treating Nonalcoholic Steatohepatitis With PioglitazoneCompletedNCT00062764Phase 2
29A Placebo Controlled Safety and Efficacy Study of INT131 Besylate in Type 2 Diabetes, With an Active ComparatorCompletedNCT00631007Phase 2
30Pioglitazone for Heroin and for Nicotine DependenceCompletedNCT01395797Phase 1, Phase 2
31Substrate Cycling in Energy MetabolismCompletedNCT00361751Phase 2
32Telmisartan Versus Losartan in Kidney TransplantationCompletedNCT01224860Phase 2
33Study to Evaluate the Safety and Analgesic Activity of ATx08-001 in Subjects With Postherpetic NeuralgiaCompletedNCT01318226Phase 2
34A Mechanistic Study of the Effects of LY518674 on High-Density Lipoprotein Cholesterol (HDL-C) MetabolismCompletedNCT00327002Phase 2
35Placebo Controlled Dose-Response Study of Rivoglitazone in Type 2 DiabetesCompletedNCT00575471Phase 2
36Placebo and Active Comparator Controlled Dose Response Study of Rivoglitazone in Type 2 DiabetesCompletedNCT00575874Phase 2
37A Clinical Trial to Evaluate the Safety and Efficacy of ZYH7 Compared to Fenofibrate in Patients With DyslipidemiaCompletedNCT01539616Phase 2
38Effects of KDT501 on Metabolic Features in Insulin Resistant SubjectsCompletedNCT02444910Phase 2
39MT2013-31: Allo HCT for Metabolic Disorders and Severe OsteopetrosisRecruitingNCT02171104Phase 2
40A Pilot Study of Vitamin D in Boys With X-linked AdrenoleukodystrophyRecruitingNCT02595489Phase 1, Phase 2
41Autologous Hematopoietic Stem Cell Gene Therapy for Metachromatic Leukodystrophy and AdrenoleukodystrophyRecruitingNCT02559830Phase 1, Phase 2
42Study of the Peroxisome Proliferator-Activated Receptor Gamma Agonist, Efatutazone vs. Placebo in Patients With Previously Treated, Unresectable Myxoid LiposarcomaRecruitingNCT02249949Phase 2
43Nutrition, Inflammation and Insulin Resistance in End Stage Renal Disease-Aim 2RecruitingNCT02278562Phase 2
44A Randomized, Placebo-Controlled, Double-Blind Pilot Study of Pioglitazone Hydrochloride in Severe, Refractory AsthmaRecruitingNCT00994175Phase 2
45Allogeneic Bone Marrow Transplant for Inherited Metabolic DisordersActive, not recruitingNCT01043640Phase 2
46Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic DisordersActive, not recruitingNCT01372228Phase 1, Phase 2
47Pioglitazone for Lung Cancer ChemopreventionActive, not recruitingNCT00780234Phase 2
48Safety and Exploratory Efficacy of HSC835 in Patients With Inherited Metabolic Disorders (IMD)Not yet recruitingNCT02715505Phase 1, Phase 2
49Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of MetabolismTerminatedNCT00668564Phase 2
50Rosiglitazone in Treating Patients With Pituitary TumorsTerminatedNCT00616642Phase 2

Search NIH Clinical Center for Peroxisome Disorders

Genetic Tests for Peroxisome Disorders

About this section

Anatomical Context for Peroxisome Disorders

About this section

MalaCards organs/tissues related to Peroxisome Disorders:

33
Kidney, Skeletal muscle, Lung, Heart, Bone, Thyroid, Monocytes

Animal Models for Peroxisome Disorders or affiliated genes

About this section

MGI Mouse Phenotypes related to Peroxisome Disorders:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053919.0ABCD1, AGPS, GNPAT, HSD17B4, PEX1, PEX7
2MP:00053898.8ABCD1, AGPS, GNPAT, HSD17B4, PEX5, PEX7
3MP:00053798.7ABCD1, AGPS, GNPAT, HSD17B4, PEX2, PEX5
4MP:00053708.2HADHB, HSD17B4, PEX1, PEX11B, PEX2, PEX5
5MP:00036317.8ABCD1, GNPAT, HSD17B4, PEX1, PEX11B, PEX2
6MP:00053787.6GNPAT, HADHB, HSD17B4, PEX1, PEX11B, PEX2
7MP:00107686.7AGPS, CAT, GNPAT, HADHB, HSD17B4, PEX1
8MP:00053765.8ABCD1, AGPS, AGXT, CAT, GNPAT, HADHB

Publications for Peroxisome Disorders

About this section

Articles related to Peroxisome Disorders:

(show top 50)    (show all 54)
idTitleAuthorsYear
1
What Drives Healthcare Worker Actions to Treat Irritant Contact Dermatitis on Hands? (27174158)
2016
2
Adult Niemann-Pick disease type B with myositis ossificans: a case report. (26338042)
2015
3
Spontaneous early-onset glomerulonephritis in a 8-week-old male Crj:CD1 (ICR) mouse. (26538815)
2015
4
Targeting a Plk1-controlled polarity checkpoint in therapy-resistant glioblastoma-propagating cells. (26573800)
2015
5
Single-port laparoscopy and extraperitoneal para-aortic lymphadenectomy for locally advanced cervical cancer: assessment after 52 consecutive patients. (24061621)
2014
6
Preface: the metamorphoses of Gilles de la Tourette syndrome. (24295632)
2013
7
Cerebrospinal Fluid Biomarkers in Clinical Subtypes of Early-Onset Alzheimer's Disease. (24401901)
2013
8
Plastin 3 ameliorates spinal muscular atrophy via delayed axon pruning and improves neuromuscular junction functionality. (23263861)
2013
9
Inflammatory pseudotumour of the liver mimicking cholangiocarcinoma. (23842773)
2013
10
Comprehensive genomic analyses associate UGT8 variants with musical ability in a Mongolian population. (23118445)
2012
11
Single stage circumferential cervical surgery (selective anterior cervical corpectomy with fusion and laminoplasty) for multilevel ossification of the posterior longitudinal ligament with spinal cord ischemia on MRI. (21113361)
2010
12
An age-related homeostasis mechanism is essential for spontaneous amelioration of hemophilia B Leyden. (19416882)
2009
13
A test of syndromic surveillance using a severe acute respiratory syndrome model. (19555611)
2009
14
Solution structure and dynamics of S100A5 in the apo and Ca2+-bound states. (19536568)
2009
15
Synergistic effects of a combination of dietary factors sulforaphane and (-) epigallocatechin-3-gallate in HT-29 AP-1 human colon carcinoma cells. (17657594)
2008
16
Comparison of nifedipine and captopril in children with pulmonary hypertension due to bronchopneumonia. (18304952)
2008
17
A randomized, crossover, open label pilot study to evaluate the efficacy and safety of Xalatan in comparison with generic Latanoprost (Latoprost) in subjects with primary open angle glaucoma or ocular hypertension. (17322603)
2007
18
Successful genetic transformation of Chinese cabbage using phosphomannose isomerase as a selection marker. (17021847)
2007
19
Simultaneous analysis of lysine, Nepsilon-carboxymethyllysine and lysinoalanine from proteins. (17997368)
2007
20
Heart failure: erythropoietin in treatment of anemia]. (17785241)
2007
21
The haematocrit and platelet target in polycythemia vera. (17156406)
2007
22
Ictal hemodynamic changes in late-onset rasmussen encephalitis. (16437569)
2006
23
RNASEL gene polymorphisms and the risk of prostate cancer: a meta-analysis. (17020975)
2006
24
The value of testing urine in non-gonococcal urethritis. (16004639)
2005
25
Fibrates modify the expression of key factors involved in bile-acid synthesis and biliary-lipid secretion in gallstone patients. (14685799)
2004
26
Induction of cytotoxic T lymphocytes following immunization with cationized soluble antigen. (15193386)
2004
27
Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function. (14871457)
2004
28
Obstructive jaundice caused by primary choledochal hydatid cyst mimicking radiologically choledochal cyst. (12596118)
2003
29
The functional and physical relationship between the DRA bicarbonate transporter and carbonic anhydrase II. (12372813)
2002
30
The role of retinoid X receptor messenger RNA expression in curatively resected non-small cell lung cancer. (11839661)
2002
31
CDB-4124 and its putative monodemethylated metabolite, CDB-4453, are potent antiprogestins with reduced antiglucocorticoid activity: in vitro comparison to mifepristone and CDB-2914. (11911951)
2002
32
Increased levels of soluble CD30 in plasma of patients with Plasmodium falciparum malaria. (11986285)
2002
33
Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-beta1 in human breast cancer cells. (11781819)
2001
34
Renal symptomatology in patients with acute intermittent porphyria. A population-based study. (11086643)
2000
35
Signaling to Rho GTPases. (10579921)
1999
36
Root resorption of first permanent molar by a supernumerary premolar. (10765756)
1999
37
Yttrium 90 DOTATOC: a new somatostatin analog for cancer therapy of neuroendocrine tumors]. (10479965)
1999
38
Molecular analysis of eight mutations in FBN1. (10647894)
1999
39
An evaluation of current risk assessment scales for decubitus ulcer in general inpatients and wheelchair users. (9619655)
1998
40
The aberrant subclavian artery. (9016231)
1997
41
Incision and drainage versus aspiration of fluctuant buboes in the emergency department during an epidemic of chancroid. (7482103)
1995
42
Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer. (8530400)
1995
43
Precise diagnosis by gene analysis and successful management of delivery in three patients with type IIB von Willebrand disease. (7948966)
1994
44
Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver. (1426884)
1992
45
Striatal D1 dopamine receptor morphochemistry following continuous or intermittent L-dopa replacement therapy. (1826481)
1991
46
Recognition by ELAM-1 of the sialyl-Lex determinant on myeloid and tumor cells. (1701275)
1990
47
Concurrence of limb girdle muscular dystrophy and myasthenia gravis. (2610729)
1989
48
Demonstration of glyoxalase II in rat liver mitochondria. Partial purification and occurrence in multiple forms. (3382669)
1988
49
Treatment of acute peripheral arterial occlusion. Results in 125 patients. (7310557)
1981
50
Paraquat poisoning: an update. (18748119)
1978

Variations for Peroxisome Disorders

About this section

Expression for genes affiliated with Peroxisome Disorders

About this section
Search GEO for disease gene expression data for Peroxisome Disorders.

Pathways for genes affiliated with Peroxisome Disorders

About this section

GO Terms for genes affiliated with Peroxisome Disorders

About this section

Cellular components related to Peroxisome Disorders according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1peroxisomeGO:00057779.4PEX1, PEX11B, TRIM37

Biological processes related to Peroxisome Disorders according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1unsaturated fatty acid metabolic processGO:003355910.4ABCD1, HSD17B4
2glycerophospholipid biosynthetic processGO:004647410.1GNPAT, HADHB
3cellular lipid metabolic processGO:00442559.6AGPS, GNPAT, HSD17B4

Sources for Peroxisome Disorders

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet